“R-Pharm” will conduct studies of radotina therapy COVID-19

The group of companies “R-Pharm” has received permission to conduct clinical studies of the drug radotin, the purpose of which will be to study its effectiveness in the treatment of patients with coronavirus infection. The project is implemented in partnership with Korean pharmaceutical company Il-Yang Pharmaceuticals.

2015, the company Il-Yang Pharmaceuticals has filed a patent application on radotin as a means to treat infections, agents which are coronaviruses SARS-CoV and MERS-CoV. In the beginning of 2020 on the site of the Center for biological defense Medical College of Korea University conducted a series of in vitro pharmacological studies, which showed that radotin significantly inhibits the replication of the virus SARS-CoV-2 48 hours after start of treatment.

“R-Pharm” will conduct a multicenter randomized study to assess the efficacy and safety of radotina in the treatment of hospitalized patients with COVID-19 in 11 hospitals in Russia.

Radotin is a low molecular tyrosine kinase inhibitor of Bcr-Abl the second generation which developed by Il-Yang Pharmaceuticals and registered with the Ministry of safety of foodstuff and medicines of the Republic of Korea in 2012 for long-term therapy of patients with chronic myeloid leukemia after failure of therapy with other tyrosine kinase inhibitors. From October 2015, the drug is registered for use in first-line treatment of patients with chronic myeloid leukemia. The safety of radotina studied in several clinical trials.

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]